Utility of assessing CD3 (+) cell chimerism within the first months after allogeneic hematopoietic stem‐cell transplantation for acute myeloid leukemia

After allogeneic hematopoietic stem‐cell transplantation (alloHSCT), the chimerism assay is used to monitor cell engraftment and quantify the respective proportions of donor/recipient cells in blood or bone‐marrow samples. Here, we aimed to better assess the utility of determining CD3(+) cell chimer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bendjelloul, Mehdi, Usureau, Cédric, Etancelin, Pascaline, Saidak, Zuzana, Lebon, Delphine, Garçon, Loïc, Marolleau, Jean‐Pierre, Desoutter, Judith, Guillaume, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303291/
https://www.ncbi.nlm.nih.gov/pubmed/35064642
http://dx.doi.org/10.1111/tan.14557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303291/
https://www.ncbi.nlm.nih.gov/pubmed/35064642
http://dx.doi.org/10.1111/tan.14557

Ejemplares similares